{"count": 1, "results": [{"_id": "33191721", "pmid": 33191721, "title": "Metformin and proliferation of cancer cell lines.", "journal": "Pediatr Endocrinol Diabetes Metab", "authors": ["Tądel K", "Wiatrak B", "Bodetko D", "Barg E"], "date": "2020-01-01T00:00:00Z", "doi": "10.5114/pedm.2020.98713", "meta_date_publication": "2020", "meta_volume": "26", "meta_issue": "4", "meta_pages": "159-166", "score": 50257.062, "text_hl": "...INTRODUCTION: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is a widely used drug in treating @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ and nowadays scientists are searching for new poten-tial and multiple roles in prevention and treatment of @<m>DISEASE_Auditory_Perceptual_Disorders</m> @DISEASE_MESH:D001308 @@@carcinogenic processes@@@. ", "citations": {"NLM": "Tądel K, Wiatrak B, Bodetko D, Barg E. Metformin and proliferation of cancer cell lines. Pediatr Endocrinol Diabetes Metab. 2020;26(4):159-166. PMID: 33191721", "BibTeX": "@article{33191721, title={Metformin and proliferation of cancer cell lines.}, author={Tądel K and Wiatrak B and Bodetko D and Barg E}, journal={Pediatr Endocrinol Diabetes Metab}, volume={26}, number={4}, pages={159-166}}"}}]}